← Back to Clinical Trials
Recruiting NCT05744973

NCT05744973 Multi-level Predictors of Structural Racism and Discrimination and Associations With Health and Well-being Across the Life Course in Diverse Families

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT05744973
Status Recruiting
Phase
Sponsor University of Colorado, Denver
Condition Racially/Ethnically Diverse Families From Urban Settings
Study Type OBSERVATIONAL
Enrollment 631 participants
Start Date 2022-11-10
Primary Completion 2028-01-01

Eligibility & Interventions

Sex All sexes
Min Age 8 Years
Max Age 18 Years
Study Type OBSERVATIONAL
Interventions
No intervention

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.

This trial targets 631 participants in total. It began in 2022-11-10 with a primary completion date of 2028-01-01.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

Minoritized populations face mutually reinforcing levels of structural disadvantage that contribute to poor health. Despite recognition that social and economic stratification, environmental conditions, and policy are critical determinants of health disparities, there has been limited effort in expanding interventions beyond the individual level to disrupt systemic causes of health. This is in part due to the challenges of describing how racism and discrimination have become systematized over time and across place.68 Studies that do examine SRD and health and well-being, focus on one level of SRD at a time, rather than examining multiple levels simultaneously. Also, the measurement of SRD at all levels has not been very detailed and more research is needed on the nuances of these experiences (e.g., frequency, timeframe, intensity). Finally, there is a need for more prospective longitudinal studies, as most research to date has been cross-sectional. In addition to comprehensively examining the four SRD levels, the current study will examine these multi- level predictors of SRD simultaneously, longitudinally, and across two sites to identify targets for multi-level interventions that will be more likely to be effective and sustainable.

Eligibility Criteria

Inclusion Criteria: * willingness to provide informed consent (parent/guardian), parental consent (parent/guardian) and assent (minor participants) and the ability for participants to comply with study requirements * They are the child's primary caregiver, i.e., they are the adult who spends the largest proportion of time caring for the child (e.g., cleaning, feeding, etc.) or they spent an exactly equal proportion to another caregiver (e.g., parents each with 50% of childcare responsibilities). * They reside in Athens-Clarke County or surrounding counties (i.e., Barrow, Jackson, Madison, Oglethorpe, and Oconee) served by the Piedmont Healthcare Coalition region * Have access to a smartphone or other internet-connected device (e.g., iPad; home computer; laptop) * Are able to read either English or Spanish UMN site: * participation in the original Family Matters Ecological Momentary Assessment sub-study * did not withdraw from the Family Matters study * ability to participate in an in-person visit (e.g., within driving distance to make an in-person visit) * The original Family Matters study enrolled vulnerable populations including children, pregnant women, disadvantaged persons, and non-English speakers. UGA site: * Child has a racial/ethnic identity reported by the parent as Black, Hispanic, or White Reside in Athens-Clarke County or surrounding counties (i.e., Barrow, Jackson, Madison, Oglethorpe, and Oconee) served by the Piedmont Healthcare Coalition region * Have access to a smartphone or other internet-connected device (e.g., iPad; home computer; laptop) * Are able to read either English or Spanish * Aged 8 to 18 years old Exclusion Criteria: * Medically necessary dietary restrictions (e.g., feeding tubes) * BMI \< 5%ile * A diagnosis of a serious and persistent mental illness * The child's parent/caregiver believes that the child is not developmentally able to participate in study components (e.g., severe autism) * The family already has one parent or one child enrolled in the study * There are no more availabilities in the family's census tract (limited to 10 households per tract). UGA also is interested in recruiting families from a range of census tracts in the Athens, GA area. If UGA finds that many families are coming from a few census tracts, they may restrict enrollment of new participants who are from those already-represented census tracts.

Contact & Investigator

Central Contact

Jerica M Berge, PhD, MPH

✉ jerica.berge@cuanschutz.edu

📞 303-724-1938

Principal Investigator

Jerica Berge, PhD

PRINCIPAL INVESTIGATOR

University of Colorado, Denver

Frequently Asked Questions

Who can join the NCT05744973 clinical trial?

This trial is open to participants of all sexes, aged 8 Years or older, up to 18 Years, studying Racially/Ethnically Diverse Families From Urban Settings. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT05744973 currently recruiting?

Yes, NCT05744973 is actively recruiting participants. Contact the research team at jerica.berge@cuanschutz.edu for enrollment information.

Where is the NCT05744973 trial being conducted?

This trial is being conducted at Athens, United States, Minneapolis, United States.

Who is sponsoring the NCT05744973 clinical trial?

NCT05744973 is sponsored by University of Colorado, Denver. The principal investigator is Jerica Berge, PhD at University of Colorado, Denver. The trial plans to enroll 631 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology